The Competition Commission approved the merger of nine entities with the pharmaceutical company Sequent Scientific Ltd (SSL). "The suggested merger entails a sequence of linked actions executed for the integration of SRL, Viyash, Symed, Appcure...
Binita Shah, Co-founder of BDR Pharmaceuticals, engaged in a conversation with India Pharma Outlook, to explain how CSR is becoming integral to HR in the Indian pharma industry, focusing on community-driven initiatives like healthcare awareness,
GSK plc announced that the European Commission has authorized Jemperli (dostarlimab) in conjunction with chemotherapy (carboplatin and paclitaxel) as a first-line therapy for adult patients with primary advanced or recurrent endometrial cancer...
Strides Pharma Science Limited has announced that its wholly owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has obtained approval from the United States Food & Drug Administration (USFDA) for Acetaminophen and Ibuprofen Tablets...
Amgen announced that the US Food and Drug Administration (FDA) has granted approval for Lumakras (sotorasib) in conjunction with Vectibix (panitumumab) for treating adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC)...
AstraZeneca's Calquence (acalabrutinib), combined with bendamustine and rituximab, has received approval in the US for treating adult patients with previously untreated mantle cell lymphoma (MCL) who cannot undergo autologous hematopoietic stem...
Indian pharmaceutical company Zydus has been granted approval by the USFDA to perform a Phase II(b) clinical trial aimed at identifying the ideal dosage strength of Usnoflast, an innovative oral NLRP3 inflammasome inhibitor for individuals with...
Alcresta Therapeutics, Inc., a prominent company in the commercial stage that specializes in creating and marketing innovative enzyme-based products, announced that the US Food and Drug Administration (FDA) has approved the expanded utilization of...
Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has authorized Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn's disease in adults. Omvoh has received approval in the US for two forms of...
Annovis Bio Inc., a company in the late stages of clinical drug development focused on innovative therapies for neurodegenerative disorders like Alzheimer’s disease (AD) and Parkinson’s disease (PD), revealed that it received the US patent for...
, CDSCO.jpg)
